Brief: Pulmatrix Receives U.S. Patent Covering iSperse Formulations For Pulmazole Program
19/08/2019 14:27
Aug 19 (Reuters) - Pulmatrix Inc PULM.O :
* PULMATRIX RECEIVES US PATENT COVERING ISPERSE™
FORMULATIONS FOR
PULMAZOLE PROGRAM
Source text for Eikon: ID:nPnWql9ya
Further company coverage: PULM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulmatrix
See all newsBrief: Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger
Pulmatrix Q2 loss narrows on clinical development hold
Pulmatrix Q1 net loss narrows, clinical development on hold
Brief: Pulmatrix Announces Closing Of Preferred Stock Transaction As Part Of Planned Merger
NASDAQ RESUMED AT 09:00 AM